Ministerio de Industria, Turismo y Comercio LogoMinisterior
 

Alerta

Resultados 265 resultados
LastUpdate Última actualización 27/04/2026 [08:33:00]
pdfxls
Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days
previousPage Resultados 175 a 200 de 265 nextPage  

FRAGMENTOMICS IN CEREBROSPINAL FLUID

NºPublicación:  WO2026051992A1 12/03/2026
Solicitante: 
CENTRE FOR NOVOSTICS [CN]
WO_2026051992_A1

Resumen de: WO2026051992A1

Various embodiments are directed to the analysis of fragmentation patterns of cell-free DNA (cfDNA) circulating in cerebrospinal fluid (CSF) and the potential applications. CSF is an important liquid biopsy sample used to study the central nervous system and related disorders, such as infection and malignancies. The characterization of fragmentation patterns of cfDNA in CSF includes the size profile, end motif, cleavage profiles, and the determination of epigenetic features, including methylation. Various applications can use one or more properties of fragmentation pattern, for example, in the determination of the proportional contribution of a particular cell types in the CSF cfDNA pool. Another purpose is the diagnosis of pathology in the central nervous system, by the detection of clinically relevant DNA (e.g., tumor fraction, pathogen). DNA fragments in CSF can be analyzed in various ways, including using short-read sequencing, and/or long-read sequencer technologies.

ANTI-SIGLEC COMPOSITIONS AND USES THEREOF FOR TREATING NEURODEGENERATIVE DISEASES

NºPublicación:  WO2026055671A1 12/03/2026
Solicitante: 
ONCOC4 INC [US]
ONCOC4, INC
WO_2026055671_PA

Resumen de: WO2026055671A1

Provided herein are anti-Siglec-10 and Siglec-8 antibody compositions and combinations thereof, and their use in the treatment of neurodegenerative diseases.

PRODUCTION METHOD OF NERVE CELLS DAMAGED BY OXIDATIVE STRESS AND APPLICATIONS THEREOF

NºPublicación:  US20260071179A1 12/03/2026
Solicitante: 
FUJIFILM CORP [JP]
US_20260071179_PA

Resumen de: US20260071179A1

An object of the present invention is to provide a method for producing nerve cells damaged by oxidative stress from a human-derived pluripotent stem cell; a culturing method for cells that allows nerve cells damaged by oxidative stress to be produced from a human-derived pluripotent stem cell; nerve cells damaged by oxidative stress; an evaluation method for a test substance, a screening method for a drug for prevention and/or treatment of a neurodegenerative disease, a screening method for a necroptosis inhibitor, and a screening method for a ferroptosis inhibitor, which use the nerve cells.According to the present invention, there is provided a production method of nerve cells damaged by oxidative stress, the method including a step a of seeding nerve cells obtained by differentiation from a human-derived pluripotent stem cell, at a cell density of 20.0×104 cells/cm2 or less by using a culture medium that substantially does not contain an antioxidant and substantially does not contain an oxidant and a step b of culturing the nerve cells by using the culture medium that substantially does not contain an antioxidant and substantially does not contain an oxidant.

Protein biomarkers for diseases associated with the contact activation system

NºPublicación:  AU2026201253A1 12/03/2026
Solicitante: 
TAKEDA PHARMACEUTICALS CO [JP]
AU_2026201253_A1

Resumen de: AU2026201253A1

Provided herein are methods and kits for analyzing a biological sample obtained from a subject having, suspected of having, or being at risk for a disease associated with the contact activation system. eb e b

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

NºPublicación:  US20260069656A1 12/03/2026
Solicitante: 
AXCELLA HEALTH INC [US]
US_20260069656_A1

Resumen de: US20260069656A1

0000 Nutritive Polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant microorganisms that make the polypeptides, vectors for expressing the polypeptides, methods of making the polypeptides using recombinant microorganisms, compositions and formulations that comprise the polypeptides, and methods of using the polypeptides, compositions and formulations.

METHOD OF CHARACTERISING A PEPTIDE, POLYPEPTIDE OR PROTEIN USING A NANOPORE

NºPublicación:  US20260072008A1 12/03/2026
Solicitante: 
UNIV OXFORD INNOVATION LTD [GB]
US_20260072008_PA

Resumen de: US20260072008A1

Provided herein are methods of characterising a peptide, polypeptide or protein and of characterising one or more proteoforms of a peptide, polypeptide or protein, using nanopores. Also provided herein are associated systems.

TRAFFICKED RNAS FOR ASSESSMENT OF CELL-CELL CONNECTIVITY AND NEUROANATOMY

NºPublicación:  US20260071269A1 12/03/2026
Solicitante: 
BROAD INST INC [US]
MASSACHUSETTS GEN HOSPITAL [US]
HARVARD COLLEGE [US]
US_20260071269_PA

Resumen de: US20260071269A1

0000 The present disclosure relates to compositions and methods for tracking and spatially localizing a cell-expressed fusion protein within the cell (with the fusion protein optionally associated with a subcellular compartment, organelle, synapse, or the like), in a manner that minimizes any disruptive impact upon the cell, at least until the detection process is initiated. Use of transcriptomics and/or barcode nucleic acid detection is employed to assess both spatial localization of intracellularly tagged fusion proteins and to establish cell-cell connectivity, e.g., in neurons across a synapse, by associating axonal identities with individual neurons at the molecular tag and transcriptome level.

BIOMARKERS FOR DETECTING AND/OR DETERMINING A TREATMENT REGIMEN FOR ALZHEIMER'S DISEASE

NºPublicación:  US20260072043A1 12/03/2026
Solicitante: 
SEQ BIOMARQUE LLC [US]
Seq Biomarque, LLC
US_20260072043_PA

Resumen de: US20260072043A1

The present disclosure provides methods for diagnosing or determining susceptibility to Alzheimer's Disease a subject by obtaining a biological sample from the subject; detecting one or more biomarkers in the biological sample selected from the group consisting of: inflammation biomarkers, oxidative stress biomarkers, insulin resistance biomarkers, and autophagy biomarkers; and diagnosing the subject with Alzheimer's Disease where one or more of the biomarkers is detected in the biological sample. Also provided are methods of treating a subject with Alzheimer's Disease comprising administering to the subject an effective amount of one or more agents for the treatment of inflammation, oxidative stress, insulin resistance, and/or autophagy.

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROLOGICAL DISEASES COMPRISING HIGHLY POTENT STEM CELLS EXPRESSING TIMP-1, MCP-1, GROa, AND IL-6, AND METHOD FOR SELECTING HIGHLY POTENT STEM CELLS

NºPublicación:  US20260072014A1 12/03/2026
Solicitante: 
MEDINNO INC [KR]
US_20260072014_PA

Resumen de: US20260072014A1

The present invention relates to a method for selecting highly potent stem cells for the treatment of neurological disease using TIMP-1, MCP-1, GROα, and IL-6, and a pharmaceutical composition for the prevention or treatment of neurological disease. According to the present invention, a specific combination of markers including TIMP-1, MCP-1, GROα, and IL-6 can be used as a biomarker for selecting stem cells with superior therapeutic (ameliorating) potential in the treatment of neurological disease. Moreover, the application of stem cells exhibiting increased expression or activity of TIMP-1, MCP-1, GROα, and IL-6 factors or the use of substances that regulate (particularly upregulate) these factors in stem cells has a remarkable therapeutic effect on neurological disease due to having high efficacy (potency) and efficiency. Furthermore, the present invention presents the higher therapeutic potential of allogeneic stem cell transplantation.

異常タンパク質の蓄積に起因する疾患の予後予測方法

NºPublicación:  JP2026042645A 11/03/2026
Solicitante: 
国立大学法人京都大学
JP_2026042645_A

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

生物学的老化の治療方法

NºPublicación:  JP2026508461A 11/03/2026
Solicitante: 
バイオビー・インコーポレイテッド
JP_2026508461_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

REGULATE GUT MICROBIOTA TO TREAT NEURODEGENERATIVE DISORDERS

NºPublicación:  EP4707410A2 11/03/2026
Solicitante: 
CALIFORNIA INST OF TECHN [US]
EP_4707410_A2

Resumen de: EP4707410A2

0001 Disclosed herein are methods and compositions that can be used to improve motor deficits and neuroinflammation in subjects in need, for example subjects suffering from neurodegenerative disorders (e.g., Parkinson's disease). Also disclosed are methods and compositions that can be used to diagnose neurodegenerative disorders, such as Parkinson's disease.

METHOD FOR THE IN VITRO DIAGNOSIS OF A NEURODEGENERATIVE DISEASE

NºPublicación:  EP4705774A1 11/03/2026
Solicitante: 
UNIV GRENOBLE ALPES [FR]
INST NAT SANTE RECH MED [FR]
Universit\u00E9 Grenoble Alpes,
Institut National de la Sant\u00E9 et de la Recherche M\u00E9dicale
CN_121039498_A

Resumen de: CN121039498A

The present invention relates to a method for the in vitro diagnosis of a neurodegenerative disease in a human or animal individual in the early stage, comprising a step comprising the detection of the presence of at least one marker selected from the group consisting of derived forms of amyloid beta (A beta) peptides, the derivative forms are selected from oligomers of the peptide and pre-fibrotic and fibrotic aggregated forms of the peptide, and derivative forms of a phosphorylated tau protein, and the derivative forms are selected from over-phosphorylated forms of the protein, aggregated forms of the protein and modified phosphorylated tau proteins resulting from one or more post-translational modifications; the presence of a marker is detected in a fecal sample of the individual.

단백질-단백질 상호작용을 유도하는 화합물을 식별하는 방법

NºPublicación:  KR20260034056A 10/03/2026
Solicitante: 
온코피아테라퓨틱스인코퍼레이티드디비에이에스케이라이프사이언스랩스
KR_20260034056_PA

Resumen de: WO2024263939A1

The present disclosure relates method of identifying a compound targeting a first protein and a second protein, wherein the first protein and/or the second protein are associated with a disease or disorder.

タンパク質-タンパク質界面を分析するための方法及び試薬

NºPublicación:  JP2026041812A 10/03/2026
Solicitante: 
レヴォリューション・メディスンズ,インコーポレイテッド
JP_2026041812_A

Resumen de: WO2018187423A1

The present disclosure provides methods and reagents useful for analyzing protein-protein interfaces such as interfaces between a presenter protein (e.g., a member of the FKBP family, a member of the cyclophilin family, or PIN1) and a target protein. In some embodiments, the target and/or presenter proteins are intracellular proteins. In some embodiments, the target and/or presenter proteins are mammalian proteins.

一种放大信号的全自动免疫检测方法、检测试剂及样本分析仪

NºPublicación:  CN121633467A 10/03/2026
Solicitante: 
深圳市新产业生物医学工程股份有限公司
CN_121633467_A

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

样本稀释液及其制备方法、应用和产品

NºPublicación:  CN121632727A 10/03/2026
Solicitante: 
中南大学湘雅三医院广州市微米生物科技有限公司
CN_121632727_A

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

Amyloid- oligomer specific fluorescent probe compound

NºPublicación:  KR20260033275A 10/03/2026
Solicitante: 
고려대학교산학협력단조선대학교산학협력단연세대학교산학협력단
KR_20260033275_PA

Resumen de: KR20260033275A

본 발명은 하기 화학식 1로 표시되는 형광 프로브 화합물에 관한 것이다: 화학식 1 JPEGpat00013.jpg4999.

结合人微管相关蛋白tau不同异构体的单克隆抗体配对及应用

NºPublicación:  CN121627878A 10/03/2026
Solicitante: 
杭州华抗生物技术有限公司
CN_121627878_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

神经颗粒蛋白在诊断和治疗脊髓小脑性共济失调3型中的应用

NºPublicación:  CN121629038A 10/03/2026
Solicitante: 
中南大学湘雅医院
CN_121629038_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

自己免疫及び炎症の処置のためのブチロフィリンA2及び関連アイソフォーム

NºPublicación:  JP2026508395A 10/03/2026
Solicitante: 
シーダーズ-サイナイ・メディカル・センター
JP_2026508395_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

免疫ベースのバイオセンサーを用いたエアロゾル化病原体の電気化学検出

NºPublicación:  JP2026508217A 10/03/2026
Solicitante: 
ワシントン・ユニバーシティ
JP_2026508217_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

ガスダーミンDに対するシングルドメイン抗体およびその使用

NºPublicación:  JP2026508175A 10/03/2026
Solicitante: 
ライニッシュフリードリッヒ-ウィルヘルムズ-ユニバーシタットボン
JP_2026508175_A

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

一种黏度响应型荧光探针、制备方法及其应用

NºPublicación:  CN121609669A 06/03/2026
Solicitante: 
陕西省人民医院(陕西省临床医学研究院)
CN_121609669_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

Fos Composition for inhibiting Fos transcription factor comprising as an active ingredient an extract of Jakyakgamchotang or a compound derived from the extract of Jakyakgamchotang

Nº publicación: KR20260030219A 06/03/2026

Solicitante:

한국한의학연구원

KR_20260030219_PA

Resumen de: EP1000000A1

The invention relates to an apparatus (1) for manufacturing green bricks from clay for the brick manufacturing industry, comprising a circulating conveyor (3) carrying mould containers combined to mould container parts (4), a reservoir (5) for clay arranged above the mould containers, means for carrying clay out of the reservoir (5) into the mould containers, means (9) for pressing and trimming clay in the mould containers, means (11) for supplying and placing take-off plates for the green bricks (13) and means for discharging green bricks released from the mould containers, characterized in that the apparatus further comprises means (22) for moving the mould container parts (4) filled with green bricks such that a protruding edge is formed on at least one side of the green bricks.

traducir